FDA: More Contaminants Found in Recalled Valsartan Heart Drugs

In this undated photo, the FDA has expanded its recall of valsartan which is found in certain drugs for heart and high blood pressure treatment. NTD TV screenshot

A brand of recalled heart failure and blood pressure medication was found to have a second, carcinogenic impurity.

The U.S. Food and Drug Administration (FDA) said that three lots of Torrent Pharmaceuticals’ valsartan drugs have NDEA, known to cause cancer in animals and is believed to be carcinogenic to humans, according to a statement on Sept. 13.